REAL-WORLD COMPARATIVE EFFECTIVENESS OF UPADACITINIB VS USTEKINUMAB FOR ULCERATIVE COLITIS AT 8-12 WEEKS

被引：0
|
作者：
Dalal, Rahul S.
Radcliffe, Marlana
Sninsky, Jared A.
Bachour, Salam
Barnes, Edward L.
Marcus, Jenna
Allegretti, Jessica R.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1722
引用
收藏
页码：S651 / S652
页数：2
相关论文
共 50 条
  • [31] Ustekinumab in ulcerative colitis- insights from the real-world data
    Veisman, Ido
    Kopylov, Uri
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2022, 10 (07) : 621 - 622
  • [32] Real-world effectiveness of adalimumab in patients with ulcerative colitis
    Armuzzi, A.
    Taxonera, C.
    Panes, J.
    Lakatos, P.
    Fisseha, N.
    Pappalardo, B.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S280 - S282
  • [33] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Taxonera, Carlos
    Olivares, David D.
    Lopez-Garcia, Olga N.
    Alba, Cristina
    GASTROENTEROLOGY, 2023, 164 (06) : S1119 - S1119
  • [34] Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis: a systematic review and meta-analysis
    Taxonera, C.
    Olivares, D.
    Olga, L. G.
    Alba, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 652 - 654
  • [35] One year effectiveness and safety of ustekinumab in Ulcerative Colitis: a multicentre real-world study from Italy
    Chiappetta, M. F.
    Viola, A.
    Mastronardi, M.
    Turchini, L.
    Carparellli, S.
    Orlando, A.
    Biscaglia, G.
    Miranda, A.
    Guida, L.
    Costantino, G.
    Scaldaferri, F.
    Bossa, F.
    Renna, S.
    Cappello, M.
    Orlando, A.
    Armuzzi, A.
    Fries, W.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S495 - S496
  • [36] Real-World Experience of Upadacitinib in Treatment of Adults With Moderate to Severe Ulcerative Colitis
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S820
  • [37] P0634 Upadacitinib Effectiveness And Safety In Patients With Ulcerative Colitis: Data From A Real-World Study
    Mocci, G.
    Scaldaferri, F.
    Napoltitano, D.
    Pugliese, D.
    Maconi, G.
    Pica, R.
    Savarino, E.
    Costa, F.
    Ceccarelli, L.
    Marzo, M.
    Elisei, W.
    Lombardi, G.
    Ribaldone, D. G.
    Bertani, L.
    Rodino, S.
    Orru, G.
    Bodini, G.
    Pranzo, G.
    Scarcelli, A.
    Luppino, I
    Ferronato, A.
    Spagnuolo, R.
    Gravina, A. G.
    Pellegrino, R.
    Vespere, G.
    Allegretta, L.
    Fanigliuolo, L.
    Grossi, L.
    Cortellini, F.
    Piergallini, S.
    Capone, P.
    Gaiani, F.
    Mucherino, C.
    D'Ascoli, B.
    Colucci, R.
    Onidi, F. M.
    Usai Satta, P.
    Picchio, M.
    Papa, A.
    Tursi, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1250 - i1250
  • [38] Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis
    Alsoud, D.
    Compernolle, G.
    Tops, S.
    Sabino, J.
    Ferrante, M.
    Thomas, D.
    De Hertogh, G.
    Vermeire, S.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I424 - I424
  • [39] REAL-WORLD USTEKINUMAB PERSISTENCE IN PATIENTS WITH ULCERATIVE COLITIS ATTAINING THE MAINTENANCE PHASE
    Zhdanava, Maryia
    Kachroo, Sumesh
    Shah, Aditi
    Ding, Zhijie
    Holiday, Christopher
    Lefebvre, Patrick
    Zhao, Ruizhi
    Kerner, Caroline
    Pilon, Dominic
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S36 - S37
  • [40] USTEKINUMAB EXPOSURE AFFECTS REAL-WORLD ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN ULCERATIVE COLITIS
    Alsoud, Dahham
    Compernolle, Griet
    Tops, Sophie
    Sabino, Joao
    Ferrante, Marc
    Thomas, Debby
    De Hertogh, Gert
    Vermeire, Severine
    Verstockt, Bram
    GASTROENTEROLOGY, 2022, 162 (07) : S819 - S819
12345